Washington, D.C., plans to use opioid settlement dollars to cover costs previously paid through its general budget, including about $2.3 million for the city’s Medicaid contribution, KFF reported Aug. 7.
The district’s fiscal year 2027 budget would also direct at least $5.5 million in opioid settlement funds to addiction treatment centers previously funded through the general budget.
More than 80 individuals and 30 city organizations signed a letter protesting the use of the settlement funds. Chad Jackson, chair of the district’s Opioid Abatement Advisory Commission, called the approach supplantation. This includes shifting money from one fund to another to free up dollars.
Christina Henderson, chair of the D.C. Council’s Committee on Health, and Attorney General Brian Schwalb wrote a letter to the district’s Department of Behavioral Health asking them to explain by July 31 how it determined the $2.3 million used to cover the city’s Medicaid contribution was legal. It is unclear whether the department met the deadline.
District law says money from its opioid abatement fund “shall supplement, and not supplant,” according to the report.
The Department of Behavioral Health said it is “committed to compliance with all statutory requirements governing opioid settlement funds.” The department also said the budget provides grants to 17 community-based providers that served nearly 9,800 residents last year, including 3,500 in medication-assisted treatment for opioid addiction.
The budget is pending a last-step 30-day “congressional review.”
At the Becker's Fall Behavioral Health Summit, taking place November 4–5 in Chicago, behavioral health leaders and executives will explore strategies for expanding access to care, integrating services, addressing workforce challenges and leveraging innovation to improve outcomes across the behavioral health continuum. Apply for complimentary registration now.
